Table 4.
Secondary outcomes
| Standard Therapy-Perioperative Lidocaine | ER Multi-Modal Analgesia-Perioperative Lidocaine | P value | |
|---|---|---|---|
| Hypotensiona | |||
| POD 1 | 0 (52); 0% | 1 (52); 1.92% | 1 |
| POD 2 | 0 (52); 0% | 0 (49); 0% | - |
| POD 3 | 0 (40); 0% | 0 (10); 0% | - |
| POD 4 | 1 (23); 4.35% | 0 (5); 0% | 1 |
| Nausea and Vomitinga | |||
| POD 1 | 11 (52); 21.15% | 6 (52); 11.54% | 0.29 |
| POD 2 | 16 (52); 30.77% | 7 (49); 14.29% | 0.06 |
| POD 3 | 9 (40); 22.50% | 5 (10); 50% | 0.12 |
| POD 4 | 8 (23); 34.78% | 2 (5); 40% | 1 |
| Pruritisa | |||
| POD 1 | 5 (52); 9.62% | 2 (52); 0.04% | 0.44 |
| POD 2 | 13 (52); 25% | 2 (49); 4.08% | 0.004 |
| POD 3 | 6 (40); 15% | 1 (10); 10% | 1 |
| POD 4 | 2 (23); 8.70% | 0 (5); 0% | 1 |
| Mental status: not awake or alerta | |||
| POD 1 | 4 (52); 7.69% | 2 (52); 0.04% | 0.68 |
| POD 2 | 6 (52); 11.54% | 0 (49); 0% | 0.03 |
| POD 3 | 3 (40); 7.50% | 0 (10); 0% | 1 |
| POD 4 | 0 (23); 0% | 0 (5); 0% | - |
| Urinary retentiona | |||
| POD 1 | 1 (52); 1.92% | 6 (52); 0.12% | 0.11 |
| POD 2 | 1 (52); 1.92% | 3 (49); 6.12% | 0.35 |
| POD 3 | 31 (40); 77.50% | 6 (10); 60% | 0.42 |
| POD 4 | 0 (22); 0% | 1 (5); 20% | 0.19 |
| Patient Satisfaction: yesa | |||
| POD 1 | 34 (52); 65.38% | 38 (52); 73.08% | 0.52 |
| POD 2 | 42 (52); 80.77% | 40 (49); 81.63% | 1 |
| POD 3 | 31 (40); 77.50% | 6 (10); 60% | 0.42 |
| POD 4 | 19 (23); 82.61% | 1 (5); 20% | 0.01 |
| Time to ambulation (hr)bc | 44.50 [22, 65.50] | 20 [13.50, 25.75] | < .001 |
| Duration of urine catheter (hr)bc | 43.50 [25.75, 67.50] | 27 [20, 42] | 0.006 |
| Time to bowel movement (hr)bc | 40 [18, 71.50] | 41.25 [28.38, 51] | 0.63 |
| Duration hospital stay (hr)bc | 146 [96.75, 288] | 72.25 [66.75, 114.12] | < .001 |
aPresented as frequency, P value from χ2 or Fisher exact tests
bPresented as median and (IQR), P value from Mann-Whitney U test
cAll these measurements calculated from the time the patient left the operating room